Fosup 150 mg

Fosup 150 mg is a prescription injectable medicine containing Fosaprepitant Dimeglumine, shown as a lyophilized injection for intravenous use only. It is mainly used with other anti-nausea medicines to help prevent chemotherapy-induced nausea and vomiting. Tiny vial, huge “please stop chemotherapy nausea before it starts” assignment.

Fosaprepitant is an injectable prodrug of aprepitant and belongs to the NK1 receptor antagonist class. It is used as part of an antiemetic regimen for prevention of nausea and vomiting associated with highly or moderately emetogenic chemotherapy.

Composition:

Fosaprepitant Dimeglumine equivalent to Fosaprepitant – 150 mg/vial

Key Information:

Brand Name: Fosup
Strength: 150 mg/vial
Active Ingredient: Fosaprepitant Dimeglumine
Dosage Form: Lyophilized injection
Medicine Type: Antiemetic / NK1 receptor antagonist
Manufacturer/Brand Shown: To be verified from physical label
Common Use: Prevention of chemotherapy-induced nausea and vomiting
Administration: Intravenous use only
Category: Prescription medicine
Pack Size: 1 vial

How It Works:

Fosup 150 mg works by blocking substance P/neurokinin-1 receptors, which are involved in triggering nausea and vomiting. By blocking this pathway, fosaprepitant helps prevent nausea and vomiting caused by chemotherapy when used with other prescribed antiemetic medicines. It is used for prevention, not for treating nausea or vomiting that has already started.

Potential Indications:

• Prevention of chemotherapy-induced nausea and vomiting
• Highly emetogenic chemotherapy-related nausea prevention
• Moderately emetogenic chemotherapy-related nausea prevention
• Other doctor-directed antiemetic use in hospital/oncology settings

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
This injection should be reconstituted, diluted, and administered only by trained medical staff.
Do not self-administer.
Official labeling commonly lists 150 mg IV infusion over 20 to 30 minutes, completed approximately 30 minutes before chemotherapy, but the final regimen must be decided by the treating doctor.
Store as per the product label and hospital pharmacy instructions. Keep out of reach of children.

Important Safety Information:

Fosaprepitant should be used carefully under medical supervision, especially in patients taking chemotherapy medicines, blood thinners such as warfarin, hormonal contraceptives, or medicines with major drug-interaction risks. Naturally, one medicine needs a social network of interactions, because biology is petty.

Possible side effects may include:

• Tiredness
• Headache
• Hiccups
• Diarrhea
• Constipation
• Injection-site pain or redness
• Dizziness
• Loss of appetite
• Allergic reaction
• Skin rash or itching

Serious symptoms such as breathing difficulty, swelling of face/lips, severe rash, peeling or blistering skin, painful urination, or severe infusion reaction symptoms should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, reconstitution instructions, dosage directions, and route of administration.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.